Literature DB >> 34172261

Investigation of the Presence of SARS-CoV-2 in Aerosol After Dental Treatment.

Hakan Akin1, Oguz Karabay2, Hande Toptan3, Halit Furuncuoglu4, Gurkan Kaya4, Emine Gulsah Akin5, Mehmet Koroglu3.   

Abstract

AIMS: The objective of the present study was to investigate the presence of SARS-CoV-2 in aerosol and COVID-19 contamination distance asssociated with ultrasonic scaling and tooth preparation.
METHODS: Twenty-four patients with COVID-19 were included in this study. Removal of supragingival plaque with ultrasonic instruments for 10 minutes and high-speed air-turbine using for the simulation of cutting the maxillary right canine tooth with a round diamond bur for 5 minutes were performed. Patients were randomly assigned to 2 groups: In group A, medium-volume suction was used during treatment. In group B, high-volume suction with an aerosol cannula was added to medium-volume suction. Prior to treatment, 5 glass petri dishes containing viral transport medium were placed in the operating room. After treatment, petri dishes were immediately delivered to a microbiology laboratory for real-time polymerase chain reaction (RT-PCR) analysis.
RESULTS: RT-PCR test results were negative for all specimens in group B. However, 5 positive test results for COVID-19 were detected in group A specimens.
CONCLUSIONS: Suction with an aerosol cannula is very important to prevent COVID-19 viral contamination via aerosol. In addition, a high-volume suction capacity (air volume) of 150 mm Hg or 325 L/min is sufficient for elimination of viral contamination. Thus, high-volume suction should be used during dental treatments in COVID-19 patients.
Copyright © 2021. Published by Elsevier Inc.

Entities:  

Keywords:  Aerosol; Covid-19; PCR test; Scaling; Suction

Mesh:

Substances:

Year:  2021        PMID: 34172261      PMCID: PMC8126174          DOI: 10.1016/j.identj.2021.05.002

Source DB:  PubMed          Journal:  Int Dent J        ISSN: 0020-6539            Impact factor:   2.512


Introduction

In December 2019, a novel coronavirus was identified among patients with pneumonia in Wuhan city, Hubei Province, China. After rapid isolation of the virus, the discovery of a new coronavirus that had never been identified in humans before was declared, officially named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by the World Health Organisation on January 7, 2020., The respiratory disease deriving from SARS-CoV-2 infection was then named COVID-19. COVID-19 has had an unprecedented impact on people across the world, and this outbreak quickly became a global public health crisis., Spread of infection is mainly through aerosols, droplets (coughing, gagging, sneezing), and direct contact, which poses a risk to the oral and nasal mucosae and conjunctivae., Self-collected saliva of most of 12 infected patients contained SARS-CoV-2 RNA. Therefore, COVID-19 transmission during dental procedures can happen through inhalation of aerosol/droplets from infected individuals or direct contact with mucous membranes, oral fluids, or contaminated instruments and surfaces. During dental procedures, transmission should be of real concern in dental clinics. At present, there is only limited evidence of airborne transmission of viable virus via aerosol particles. Thus, the aim of the present study was to investigate the presence of SARS-CoV-2 in aerosol and COVID-19 contamination distance during ultrasonic scaling and tooth preparation. The first hypothesis of the study was that SARS-CoV-2 would be detected in aerosol during ultrasonic scaling and tooth preparation with medium-volume suction in the clinical environment. The second hypothesis of the study was that there is no difference in aerosol contamination between medium- and high-volume suctions.

Methods

For this study, 24 patients (6 female and 18 male) with COVID-19 confirmed by real-time polymerase chain reaction (RT-PCR) who had been admitted to the Sakarya Provincial Health Directorate Sakarya University Training and Research Hospital were recruited. Patients underwent a baseline dental examination. Inclusion criteria was understanding of the study requirements and medical treatment taking place in the hospital. Participant exclusion criteria were age younger than 18 years, pregnancy, edentulousness, exhaustion, or difficulty walking. In addition, volunteer patients were asked to expectorate into a screw-cap plastic tube which contains viral transform medium and RT-PCR tests were performed on these samples in the plastic tube. The patients have negative results were not included in the present study. Treating patients with COVID-19 was difficult for patients and clinicians. Thus, a limited number of patients were included in the present study. Written informed consent was obtained from all study participants before study entry. The Ethics Committee of Sakarya University and General Directorate of Health Services, Republic of Turkey Ministry of Health approved the study protocol (protocol number: 16214662/050.01.04/143), and the trial was conducted in accordance with the Declaration of Helsinki. Five glass petri dishes with dimensions of 75 mm × 15 mm were sterilised for each patient and placed on the floor in a 12 m2 operating room (2.9 m × 4.15 m). Each corner of the room received one petri dish, and the fifth dish was placed in the dental unit's cup holder (Stern Weber S200 Plus, Cefla Dental Group). The dental unit was set in the reclining position and the headrest had a ground clearance of 75 cm. This position was stored as position A in the dental unit, which is able to store different positions. Thus, all patients were treated in the same position (Figure).
Figure

A schematic diagram of operating room, treatment position of the dental unit, and petri dishes positions.

A schematic diagram of operating room, treatment position of the dental unit, and petri dishes positions. Three milliliters of viral transport medium, which comes in a screw-cap plastic tube, were poured into each glass petri dish. Two clinicians (HA and GK) with over 10 years of clinical experience performed treatment protocol for all patients. In addition, operations were assisted by the other 2 experienced clinicians (EGA and HF). The treatment protocol consisted of 2 sessions. Removal of supragingival plaque was the first session, performed with ultrasonic instruments (SC-A3, Cefla Dental Group). A 40,000-cycle per second (Hz) ultrasonic scaler was set at maximum power for all trials. The coolant volume of the ultrasonic scaler was adjusted to 50 mL/min, a volume reported as ideal for clinical use. Treatment time was standardised at 10 minutes. The second session consisted of use of a high-speed air-turbine (Slent Power Evo 4LK, Cefla Dental Group). Immediately following scaling, a simulation of cutting of the maxillary right canine tooth with a round diamond bur was performed. It was ensured that the bur did not touch the teeth. Second sessions lasted 5 minutes. Water cooling was adjusted to 15 mL/min, and the aerator was set at maximum power for all trials. Patients were randomly assigned to 2 groups: In group A, medium-volume suction was used during treatments. In group B, high-volume suction with an aerosol cannula (1.5 cm diameter and 12 cm height) was used along with medium-volume suction. Dürr Vs1200 suction system (Dürr Dental SE; max unimpeded flow rate 2400 L/min, auxiliary air valve setting −170 mbar/hPa, max fluid rate of flow 24 L/min) was used. In addition, the suction machine was at a distance of 19 m from the dental unit. Furthermore, two flowmeters (Cattani 59168 and Cattani 040840, Cattani) were used to determine the suction capacity of the medium- and high-volume suctions. Medium-volume suction had a suction capacity of 80 mm Hg and 158 L/min (air volume), whereas high-volume suction had 150 mm Hg and 325 L/min suction capacity (air volume). All clinicians wore masks (Type 7502, 3M) and safety glasses at all times during the treatments. Furthermore, sterile surgery uniforms and hair bonnets were used. When each operation was finished, the clinicians and patient left the operating room to allow the deposition of droplets and aerosols. After 30 minutes, viral transport medium was transferred from the petri dishes to screw-cap plastic tubes using a sterile syringe. For each patient, 5 specimens were obtained. Specimens were immediately delivered to the microbiology laboratory and stored at 2 to 8 °C. Specimens were taken to a negative-pressure room in a Class 2-a biosafety cabinet. They were then vortexed for at least 5 seconds. Afterwards, RNA isolation was performed using the EZ1 Virus Mini Kit v2.0 in a Biorobot EZ1 (Qiagen, Germany) device. Elution of 60 µl of 400 µl sample was taken and used as a template in RT-PCR reaction. For RT-PCR study, a 10 µl master mix, 2 µl of primer, and 8 µl of RNA mixture were prepared per sample with a Genesis Real-Time PCR SARS-CoV-2 kit (Primer Design). Reactions were carried out at the following time and temperature, with total reaction volumes of 20 µl. At the end of each reaction, a cycle treshold value of less than 45 was interpreted as positive for SARS-CoV-2 RNA. Data were recorded, and statistical analysis was performed using SPSS (Version 22.0). Relative risk tests were used to analyze the data with a 95% confidence interval.

Results

Background information for the 24 patients involved in this study was demonstrated in Table 1. Polymerase chain reaction (PCR) test results are presented in Table 2. According to the relative risk analysis, medium volume has negative effect on the PCR test results (0.917). PCR test results were negative for all specimens in group B. However, positive test results (8.3% according to relative risk analysis) were detected for 5 patients in group A. These were specimen numbers 1, 2 (twice), 3, and 5 (twice), whereas the specimens of number 4 exhibited no positive PCR test results for any patients (Table 2).
Table 1

Background information for the 24 patients involved in this study.

PatientAge, ySexSymptomsDate of diagnosis/date of the dental treatmentCT values of PCR test (diagnosis)
129MaleFever, cough09.06.202010.06.202019.08
229MaleFever, weakness08.06.202010.06.202018.79
330MaleFever, headache08.06.202011.06.202025.61
442MaleDifficulty breathing, fever, back pain08.06.202011.06.202032.54
550MaleCough, weakness17.07.202020.07.202031.9
664MaleCough weakness17.07.202020.07.202029.57
721MaleFever, weakness06.08.202006.08.202023.92
857MaleFever, cough, palpitation, diarrhoea09.08.202011.08.202019.05
948FemaleFever, cough31.07.202002.08.202022.13
1051FemaleFever, cough, loss of smell28.07.202002.08.202027.4
1152FemaleCough, weakness29.07.202001.08.202026.06
1255MaleCough, weakness, loss of smell05.08.202006.08.202032.51
1342MaleCough10.08.202011.08.202024.93
1454MaleFever, cough31.07.202001.08.202018.56
1565MaleFever, cough, joint pain07.08.202010.08.202023.92
1629MaleFever, cough27.08.202029.08.202012.52
1762MaleMuscle pain, joint pain03.08.202004.08.202017.38
1863MaleDifficulty breathing27.08.202001.09.202022.12
1956FemaleCough, weakness, difficulty breathing04.09.202008.09.202024.22
2040FemaleCough, nausea,09.09.202010.09.202020.88
2149MaleCough, difficulty in breathing10.09.202012.09.202028.23
2264FemaleCough, difficulty in breathing, weakness, inappetence09.09.202012.09.202024.91
2375MaleCough12.09.202013.09.202025.66
2470MaleFever22.09.202023.09.202018.57

CT, cycle treshold; PCR, polymerase chain reaction.

Table 2

The results of PCR test for the samples in the two groups.

Negative
Positive
Group AGroup BGroup A*Group B
Number 11112131.63⁎⁎-
Number 21012224.4⁎⁎-
21.6⁎⁎
Number 31112122.4⁎⁎-
Number 41212--
Number 51012231.02⁎⁎-
19.4⁎⁎

Positive results were seen in 5 patients.

Cycle treshold values of polymerase chain reaction test.

Background information for the 24 patients involved in this study. CT, cycle treshold; PCR, polymerase chain reaction. The results of PCR test for the samples in the two groups. Positive results were seen in 5 patients. Cycle treshold values of polymerase chain reaction test.

Discussion

SARS-CoV-2 RNA was detected in samples of group A. Thus, the first hypothesis that SARS-CoV-2 would be detected in aerosol during ultrasonic scaling and tooth preparation with medium-volume suction in the clinical environment was accepted. However, no SARS-CoV-2 RNA was detected in group B using the PCR testing. Therefore, the second hypothesis of the study was there is no difference in aerosol contamination between medium- and high-volume suctions was rejected. In the dental literature, a limited number of studies have been performed regarding COVID-19 contamination during dental treatment. Ultrasonic scaling and cutting procedures with high-speed air-turbine were performed under water cooling. The present study is the first study in the dental literature to investigate possible SARS-CoV-2 contamination via aerosol. On the other hand, Bennett et al. demonstrated that aerosol peaks tended to decrease to background levels within 10 to 30 minutes, caused by rapid deposition of particles after aerosol generation at the patient head height. Consistent with this study, Veena et al. found that the aerosol cloud could remain in the air up to 30 minutes after scaling. Thus, in the present study, 30 minutes passed before obtaining specimens from petri dishes to allow deposition of droplets and aerosols. In addition, some of the samples from group C demonstrated positive results in petri dishes 1, 2, and 3. These were far away from the source. Therefore, these results can only be explained by contamination from aerosols. Furthermore, according to BS EN ISO 10637, high-volume system has an air intake of more than 250 L/min at each cannula connector of the largest bore operating hose. In addition, Holliday et al. used two different flow rates, 40 L/min low-volume suction and 159 L/min medium-volume suction. In the present study, 325 L/min high-volume suction and 158 L/min medium-volume suction was used. Gloves, mask, and glasses are the main personal protective equipment used during dental treatment. However, there is resistance to the use of protective equipment in dental care. In 1990, the American Dental Association appealed to the courts against the mandatory use of protective equipment, claiming that no professional had contracted the disease. In last 2 decades, knowledge about AIDS and now COVID-19 has pushed dentists to review safety standards. The American Dental Association and the US Centers for Disease Control and Prevention have recommended using high-volume suction during dental treatment to minimise dissemination of droplets, spatter, and aerosols.10, 11, 12 Nevertheless, dentists have resisted this recommendation. The present study demonststes the importance of high-volume suction for infection control during dental treatments. In addition, based on the results of the present study, high-volume suction with an aerosol cannula is very important to prevent SARS-CoV-2 virus contamination via aerosol from patient to patient or from patient to clinician. Moreover, clinicians could mitigate the potential risk of the virus using UV air disinfection devices or HEPA-filter air cleaner devices in the operating rooms. The limitation of the present study is that a few samples (5 in a room) were evaluated. The samples could be placed around the dental unit. In addition, clinicians’ masks and safety glasses were not evaluated. On the other hand, the bur was not touched to the teeth when simulating the cutting teeth. Thus, high-energy particles were not produced. Moreover, during this study, only one dental unit was used. However, 9 additional dental units were attached to the same suction system. This study did not evaluate whether sufficient pressure can be supplied when all dental units are used simultaneously. In future studies, suction system capacity should be evaluated when all dental units are used at the same time.

Conclusions

Within the limitations of the study, high-volume suction with an aerosol cannula is very important to prevent COVID-19 viral contamination via aerosol. High-volume suction of 150 mm Hg or 325 L/min is sufficient to prevent COVID-19 contamination. Thus, high-volume suction should be used during dental treatment.
  10 in total

1.  Microbial aerosols in general dental practice.

Authors:  A M Bennett; M R Fulford; J T Walker; D J Bradshaw; M V Martin; P D Marsh
Journal:  Br Dent J       Date:  2000-12-23       Impact factor: 1.626

2.  Guidelines for infection control in dental health-care settings--2003.

Authors:  William G Kohn; Amy S Collins; Jennifer L Cleveland; Jennifer A Harte; Kathy J Eklund; Dolores M Malvitz
Journal:  MMWR Recomm Rep       Date:  2003-12-19

Review 3.  A laboratory comparison of evacuation devices on aerosol reduction.

Authors:  Mary E Jacks
Journal:  J Dent Hyg       Date:  2002

4.  Dissemination of aerosol and splatter during ultrasonic scaling: a pilot study.

Authors:  H R Veena; S Mahantesha; Preethi A Joseph; Sudhir R Patil; Suvarna H Patil
Journal:  J Infect Public Health       Date:  2015-01-03       Impact factor: 3.718

Review 5.  COVID-19 Transmission in Dental Practice: Brief Review of Preventive Measures in Italy.

Authors:  R Izzetti; M Nisi; M Gabriele; F Graziani
Journal:  J Dent Res       Date:  2020-04-17       Impact factor: 6.116

Review 6.  COVID-19: a new turning point for dental practice.

Authors:  Flávio Freitas Mattos; Isabela Almeida Pordeus
Journal:  Braz Oral Res       Date:  2020-07-15

7.  Coronavirus disease 2019 (COVID-19): challenges and management of aerosol-generating procedures in dentistry.

Authors:  Kamran Ali; Mahwish Raja
Journal:  Evid Based Dent       Date:  2020-06

8.  Evaluating contaminated dental aerosol and splatter in an open plan clinic environment: Implications for the COVID-19 pandemic.

Authors:  Richard Holliday; James R Allison; Charlotte C Currie; David C Edwards; Charlotte Bowes; Kimberley Pickering; Sarah Reay; Justin Durham; Joanna Lumb; Nadia Rostami; Jamie Coulter; Christopher Nile; Nicholas Jakubovics
Journal:  J Dent       Date:  2021-01-06       Impact factor: 4.379

9.  A detailed report on the measures taken in the Department of Conservative Dentistry and Periodontology in Munich at the beginning of the COVID-19 outbreak.

Authors:  Christian Diegritz; Jürgen Manhart; Katharina Bücher; Béatrice Grabein; Günther Schuierer; Jan Kühnisch; Karl-Heinz Kunzelmann; Reinhard Hickel; Christina Fotiadou
Journal:  Clin Oral Investig       Date:  2020-07-01       Impact factor: 3.606

10.  Guidance for dental treatment of patients with disabilities during COVID-19 pandemic.

Authors:  Eun-Jung Kwak; Jieun Kim; Hiran Perinpanayagam; Kee-Yeon Kum
Journal:  J Dent Sci       Date:  2020-08-13       Impact factor: 2.080

  10 in total
  5 in total

1.  Aerosol Reduction of 2 Dental Extraoral Scavenger Devices In Vitro.

Authors:  Dorottya Gheorghita; Fruzsina Kun Szabó; Tibor Ajtai; Szabolcs Hodovány; Zoltán Bozóki; Gábor Braunitzer; Márk Ádám Antal
Journal:  Int Dent J       Date:  2022-06-02       Impact factor: 2.607

2.  Visualization of droplets produced by dental air turbines that require infection control measured during coronavirus 2019 outbreaks.

Authors:  T Ohya; K Nakagawa; Y Arai; H Kato
Journal:  J Hosp Infect       Date:  2021-10-09       Impact factor: 3.926

3.  Droplet size distribution, atomization mechanism and dynamics of dental aerosols.

Authors:  Emine Kayahan; Min Wu; Tom Van Gerven; Leen Braeken; Lambert Stijven; Constantinus Politis; M Enis Leblebici
Journal:  J Aerosol Sci       Date:  2022-07-22       Impact factor: 4.586

Review 4.  SARS-CoV-2 air sampling: A systematic review on the methodologies for detection and infectivity.

Authors:  Priscilla G Silva; Pedro T B S Branco; Ruben R G Soares; João R Mesquita; Sofia I V Sousa
Journal:  Indoor Air       Date:  2022-08       Impact factor: 6.554

5.  Paradigm shift in infection control practices in dental clinics in response to COVID-19 among dental professionals in Thailand.

Authors:  Phisut Amnuaiphanit; Thanasak Thumbuntu; Piyada Gaewkhiew; Ruchanee Salingcarnboriboon Ampornaramveth
Journal:  Front Oral Health       Date:  2022-09-21
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.